Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 6;13(15):e036496.
doi: 10.1161/JAHA.124.036496. Epub 2024 Aug 5.

Unveiling the Causal Relationship of Cardiovascular Burden in Primary Aldosteronism by Genome-Wide Association and Mendelian Randomization: A Possible Solution?

Affiliations
Editorial

Unveiling the Causal Relationship of Cardiovascular Burden in Primary Aldosteronism by Genome-Wide Association and Mendelian Randomization: A Possible Solution?

Cheng-Hsuan Tsai et al. J Am Heart Assoc. .
No abstract available

Keywords: Editorials; cardiovascular disease; genome‐wide association study; primary aldosteronism.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Causal relationship of cardiovascular disease in primary aldosteronism.
Illustration of potential genetic risks associated with cardiovascular diseases in patients with primary aldosteronism, as identified through genome‐wide association and Mendelian randomization studies. CAD indicates coronary artery disease; and CHF, congestive heart failure.

Comment on

Similar articles

References

    1. Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta‐analysis. Lancet Diabetes Endocrinol. 2018;6:41–50. doi: 10.1016/S2213-8587(17)30319-4 - DOI - PubMed
    1. Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC, Hung CS, Lin YH. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens. 2021;35:131–147. doi: 10.1038/s41371-020-00426-y - DOI - PMC - PubMed
    1. Inoue K, Naito T, Fuji R, Sonehara K, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K. Primary aldosteronism and risk of cardiovascular outcomes: genome‐wide association and Mendelian randomization study. J Am Heart Assoc. 2024. doi: 10.1161/JAHA.123.034180 - DOI - PMC - PubMed
    1. Naito T, Inoue K, Sonehara K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Kishimoto S, et al. Genetic risk of primary aldosteronism and its contribution to hypertension: a cross‐ancestry meta‐analysis of genome‐wide association studies. Circulation. 2023;147:1097–1109. doi: 10.1161/CIRCULATIONAHA.122.062349 - DOI - PMC - PubMed
    1. Le Floch E, Cosentino T, Larsen CK, Beuschlein F, Reincke M, Amar L, Rossi GP, de Sousa K, Baron S, Chantalat S, et al. Identification of risk loci for primary aldosteronism in genome‐wide association studies. Nat Commun. 2022;13:5198. doi: 10.1038/s41467-022-32896-8 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources